HBK INVESTMENTS L P
Institutional investor · Portfolio as of Q2 2019
Top Holdings589 positions
VANTIV INC | 13M | $1.6B | 14.1% | — | — | 1 qtr | New 98 |
RED HAT INC | 6.5M | $1.2B | 10.7% | — | — | 2 qtrssince 2019-Q1 | Increased 80 |
ALTABA INC | 14.9M | $1B | 9.0% | — | — | 2 qtrssince 2019-Q1 | Increased 64 |
ANADARKO PETE CORP | 14.3M | $1B | 8.8% | — | — | 2 qtrssince 2019-Q1 | Increased 100 |
WELLCARE HEALTH PLANS INC | 2.4M | $697.2M | 6.1% | — | — | 1 qtr | New 98 |
FIRST DATA CORP NEW | 25.5M | $689.9M | 6.0% | — | — | 2 qtrssince 2019-Q1 | Increased 76 |
| 2.2M | $492.3M | 4.3% | — | — | — | Increased — | |
| 1.5M | $280.1M | 2.4% | — | — | — | Increased — | |
TRIBUNE MEDIA CO | 4.3M | $198.8M | 1.7% | — | — | 2 qtrssince 2019-Q1 | Unchanged 0 |
| 175M | $171.8M | 1.5% | — | — | 1 qtr | New 69 | |
| 3.5M | $161.5M | 1.4% | — | — | 2 qtrssince 2019-Q1 | Increased 77 | |
CYPRESS SEMICONDUCTOR CORP | 7.2M | $160.1M | 1.4% | — | — | 2 qtrssince 2019-Q1 | Increased 77 |
PETROLEO BRASILEIRO SA PETRO | 7.9M | $111.8M | 1.0% | $3.97 | -0.24% | 2 qtrssince 2019-Q1 | Decreased 0 |
| 2.4M | $111.3M | 1.0% | — | — | — | New — | |
| 113.8M | $108.3M | 0.9% | — | — | 2 qtrssince 2019-Q1 | Increased 44 | |
EQT CORP | 5M | $79.1M | 0.7% | $17.27 | -15.68% | 2 qtrssince 2019-Q1 | Increased 62 |
| 500,137 | $65.1M | 0.6% | — | — | 2 qtrssince 2019-Q1 | Increased 67 | |
SINA CORP | 1.5M | $62.6M | 0.5% | — | — | 2 qtrssince 2019-Q1 | Increased 60 |
| 54M | $50.6M | 0.4% | — | — | 2 qtrssince 2019-Q1 | Increased 45 | |
TAKEDA PHARMACEUTICAL CO LTD | 2.6M | $46.7M | 0.4% | $19.07 | -13.11% | 2 qtrssince 2019-Q1 | Decreased 0 |
HBK INVESTMENTS L P manages $11.5B across 589 positions as of Q2 2019. Top holdings: WP (14.1%), RHT (10.7%), AABA (9.0%). Fund DNA: Momentum Trader. HoldingsIntel Score: 2/5.0.
Active quarter - 100 new positions, 610 exits, 42 increased. Top move: APC (INCREASED, conviction 100). Portfolio: $11.5B across 589 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR